Healthcare · Profile from Healthcare Research Companion
Bright Health Group (NeueHealth, Inc.)
The Minneapolis insurtech that promised to fix health insurance by tying each plan to a single "Care Partner" health system, raised roughly $1.5bn of venture money and ~$924m in the largest IPO in Minnesota history, grew to about a million members in five years, and then lost more than $2.5bn in two years on ACA exchange and Medicare Advantage risk. It exited insurance entirely in 2022–2023, sold its California Medicare plans to Molina, left a liquidated Texas subsidiary and a ~$380m CMS repayment plan behind, renamed itself NeueHealth, and was taken private by its largest venture investor, New Enterprise Associates, in October 2025.
At a glance
- Founded
- 2015, Minneapolis, Minnesota (first health plans sold for the 2017 plan year, verify)
- Founders
- Bob Sheehy (former CEO of UnitedHealthcare), Kyle Rolfing (founder of consumer-directed health company Definity Health, sold to UnitedHealth in 2004) and Tom Valdivia (physician executive)
- Headquarters
- Minneapolis (Bloomington), Minnesota until 2024; moved to Doral, Florida with the NeueHealth rebrand
- Ownership / structure
- Venture-backed private company 2015–2021; NYSE: BHG (IPO June 2021), renamed NeueHealth and re-ticketed NEUE (January 29, 2024); taken private by an affiliate of New Enterprise Associates (NEA) and a consortium of preferred holders, closed October 2, 2025
- Leadership (2026)
- G. Mike Mikan, president and CEO (CEO since April 2020; former UnitedHealth CFO and interim CEO, former Best Buy interim CEO); continuing after take-private (verify)
- Segment and buyer
- Started as a payer (ACA individual plans, Medicare Advantage); since 2023–24 a value-based care enabler and provider (NeueCare clinics, NeueSolutions/ACO REACH). Payers: CMS (ACO REACH and Medicare Advantage), commercial and MA plans paying NeueHealth under value-based contracts, ACA members (until 2022)
- Scale
- Peak: ~$4.0bn revenue (2021) and over 1m health-plan members entering 2022 (reported). NeueHealth: ~$1.16bn revenue (2023), ~$937m (2024); ~483k "consumers served" in 2024 and ~717k early 2025 (reported)
- Capital raised / valuation
- ~$1.5–1.6bn of private equity (2016–2020, reported); IPO raised ~$924m at $18/share (~$11bn valuation); $750m convertible preferred from Cigna and NEA (December 2021, closed January 2022); $175m further preferred (October 2022); take-private at $7.33/share (post 1-for-80 reverse split), enterprise value ~$1.465bn including preferred rolled over
- Signature moves (incl. failures)
- Care Partner alignment model; mega-rounds and multi-state ACA expansion; Brand New Day and Central Health Plan (California MA); Florida clinic roll-up (NeueHealth); 2021 IPO (–79% in six months); Cigna/NEA $750m preferred; full ACA exit (2022) and >$1bn risk-adjustment liabilities; sale of California MA to Molina (2023) and Texas liquidation; NeueHealth rebrand and ACO REACH pivot (2024); NEA take-private (2025)
10 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2015
Founding and Care Partner Model
Founding / launch
2019
Mega Rounds and Rapid Expansion
Funding round / geographic expansion
2020
Brand New Day California MA
Acquisition
2021
Cigna NEA 750M Preferred
Funding round (private placement in a public company) / strategic investment
2021
NYSE IPO
IPO
2021
NeueHealth Care Delivery Rollup
Acquisition / vertical integration
2022
ACA Exit and Risk Adjustment Shock
Divestiture / restructuring (market exit)
2023
Molina Sale and Insurance Exit
Divestiture / regulatory (insolvency of a subsidiary) / restructuring
2024
NeueHealth Rebrand and ACO REACH
Pivot / restructuring (rename, HQ move, refinancing)
2025
NEA Take Private
Take-private (merger with an investor affiliate)